Inhalation anesthetics and oncogene
Inhalation anesthetics and oncogene
批准号:
01440063
负责人:
SHIMADA Yasuhiro
金额:
$10.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1991
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although almost cancer patients are undergone with general anesthesia, a few researchers and anesthesiologists are interest in the interaction between cancer cells and anesthesia. So we have been doing researches of the influence of anesthesia on cancer cells in order to try to establish the best anesthesia for cancer patients. We put on a focus on "oncogene". We guessed that anesthesia agents might influence oncogene.We studied as follows; (1)halothane and the expression of c-myc protein in human leukemia cells in vitro, (2)halothane and the amplification of N-myc in neuroblastoma in vitro. Results were as follows; (1)the expression of c-myc protein did not change during/after halothane exposure, (2)the amplification of N-myc did not also change during/after halothane exposure.As far as our results, anesthesia did not influence oncogene. There are many other oncogenes. Some of other oncogene might change during/after anesthesia.Furthermore, we did other researches. We tried to evaluate the change of antigens in cancer cells during/after anesthesia in vitro. We studied as follows; (1)halothane and the expression of HLA-DR antigen in melanoma cells, (2)halothane/sevoflurane and the expression of intercellular adhesion molecule-1 (ICAM-1) in melanoma cells. The results were as follows; (1)the expression of HLA-DR in melanoma cells increased after halothane exposure, (2)the expression of ICAM-1 in melanoma cells decreased during halothane/sevoflurane exposure.These results suggested that anesthetic agents influence on antigen expression in cancer cells, and that the change might decrease the recognition of immune surveillance. Anesthetic agents might deteriorate cancer patients.Anesthesiologists and surgeons should be aware that anesthesia might deteriorate cancer patients, and had better continue to do research on the relation between cancer and anesthesia.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
三毛 紀夫: "ハロセンのがん遺伝子増幅に及ぼす影響について" 麻酔. 40. S349 (1991)
Norio Mike:“氟烷对癌症基因扩增的影响”麻醉 40. S349 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeyama, H.: "Tumor necrosis factor expression by human ovarian carcinoma in vivo" Cancer Research. 51. 4476-4480 (1991)
Takeyama, H.:“人卵巢癌体内肿瘤坏死因子的表达”癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujiwara, Y.: "Halothane and proto-oncogene c-myc expression" Anesthesia and Analgesia. 82. 84 (1991)
Fujiwara, Y.:“氟烷和原癌基因 c-myc 表达”麻醉和镇痛。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
藤原 祥裕: "Halothane and protoーoncogene cーmyc expression" Anesthesia and Analgesia. 82. S84 (1991)
Yoshihiro Fujiwara:“氟烷和原癌基因 c-myc 表达”麻醉与镇痛 82. S84 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
若宮 伸隆: "Expression of Hanganutziu-Deicher antigen in activated human T lymphocytes" Biochem.Biophys.Res.Comm.81. 310-315 (1991)
Nobutaka Wakamiya:“Hanganutziu-Deicher 抗原在活化的人 T 淋巴细胞中的表达”Biochem.Biophys.Res.Comm.81 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Mechanisms of increased vascular permeability associated with sympathetic excitability and the development of treatment strategy of ARDS.
-
批准号:16390448
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.94万
-
财政年份:2004
-
负责人:SHIMADA Yasuhiro
-
依托单位:
Study on the Neural Network relating to Pulmonary Vascular Permeability and Cloning of its Receptor
-
批准号:12470318
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2000
-
负责人:SHIMADA Yasuhiro
-
依托单位:
Study of the mechanism of lung vascular permeability in pulmonary edema
-
批准号:09470325
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.34万
-
财政年份:1997
-
负责人:SHIMADA Yasuhiro
-
依托单位:
Study on the Mechanism of Increased Vascular Permeability in Pulmonary Edema
-
批准号:06454443
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1994
-
负责人:SHIMADA Yasuhiro
-
依托单位:
Mechanism and the Effects of Anesthetics and Anesthetic Depth on the Development of Neurogenic Pulmonary Edema.
-
批准号:61480332
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1986
-
负责人:SHIMADA Yasuhiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于c-Myc/GLS1正反馈回路的谷氨酰胺代谢和氨死亡研究加味肺复方干预NSCLC免疫逃逸的作用机制
-
批准号:2026JJ81859
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王华中
-
依托单位:
YBX1介导的HOXA9 mRNA稳定性影响c-MYC转录在胃癌进展中的机制研究
-
批准号:2026JJ82359
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:卢太亮
-
依托单位:
ZDHHC9 介导 c-Myc 的棕榈酰化调控 VSMCs代谢重编程促进胸主动脉夹层进展的作用机制研究
-
批准号:ZCLKLY26H0202
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙乐波
-
依托单位:
PUM3通过稳定COL10A1表达调节TGF-β/c-MYC和Notch1通路促进前列腺癌骨转移进程的机制研究
-
批准号:JCZRLH202600428
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于SCARB1-RORα-FBW7-c-Myc正反馈环的食管鳞癌胆固醇代谢重编程机制及靶向干预策略研究
-
批准号:2026JJ80901
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:苏敏
-
依托单位:
c-Myc 通过上调 SLC1A5 介导的谷氨酰胺代谢重编程增强淋巴瘤细胞铜死亡敏感性
-
批准号:ZCLMRY26H0801
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨陈
-
依托单位:
基于c-Myc/SLC1A5轴研究参芪消癥饮重编程肺癌谷氨酰胺代谢诱导免疫原性细胞死亡的机制
-
批准号:2026JJ82571
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭玲娟
-
依托单位:
CUEDC2通过激活糖酵解介导的c-Myc蛋白乳酸化修饰上调PD-L1促进非小细胞肺癌免疫逃逸的机制研究
-
批准号:2026JJ81641
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:佘科霖
-
依托单位:
靶向ZNF471糖基化通过调控c-Myc/PD-L1轴重塑免疫微环境增强舌鳞癌免疫治疗疗效的机制研究
-
批准号:2026JJ81965
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王鸿涵
-
依托单位:
c-Myc/ASS1介导肠上皮细胞瓜氨酸耗竭在急性放射性小肠损伤中的作用机制研究
-
批准号:2026JJ80904
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杜洁
-
依托单位: